Explore the factors keeping CRON in focus, including cannabis innovation, financial flexibility, consumer demand trends, and ...

Shares of Cronos Group Inc. CRON rallied 1.09% to $2.77 Monday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.86% to ...

Cronos Group (NASDAQ: CRON) stock jumped 9.4% through 11:30 a.m. ET Tuesday after beating Wall Street forecasts for Q3 earnings this morning. Heading into the report, analysts expected Cronos to do ...

Cronos Group Inc (NASDAQ:CRON) is one of the best CBD stocks to buy right now. The stock is up roughly 40% over the past year ...

Low-priced cannabis stocks regain attention as stronger sales, leaner operations, and improving small-cap sentiment revive ...

Shares of Cronos Group (NASDAQ: CRON) were sinking 4.1% lower as of 10:57 a.m. ET on Tuesday and fell as much as 5.7% earlier in the day. The decline came after the U.S. Drug Enforcement ...

Short-seller Andrew Left is on trial in Los Angeles for securities fraud, accused of market manipulation through misleading ...

For its second quarter, Cronos -- which reports in U.S. dollars -- took in nearly $27.8 million in revenue, a figure almost 50% higher than the $19 million it earned in the same period of 2023. On a ...

The Canadian market has faced challenges recently, with first-quarter data indicating a technical recession amid ongoing inflation pressures. Despite these hurdles, the concept of penny stocks remains ...

Investors are clamoring to invest in publicly-traded cannabis companies as the legal marijuana market expands. Despite the clear growth potential in this industry, investors still need to exercise ...

TORONTO, March 16, 2026 (GLOBE NEWSWIRE)-- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, ...

Detailed price information for Cronos Group Inc (CRON-Q) from The Globe and Mail including charting and trades.